Robert Fremeau

Company: BrainStorm Therapeutics

Job title: Founder and CSO

Seminars:

Modeling Neurological Disorders Using Patient-Derived Human Brain Organoids 9:55 am

CNS drug discovery needs a paradigm shift. Patient-derived brain organoids can revolutionize CNS drug discovery Patient-derived Rett syndrome and CDKL5 deficiency disorder cortical brain organoids exhibit aberrant functional disease phenotypes amenable to HTS. Phenotypic screening identified clinical candidates for Rett syndrome advancing to a Phase 2 clinical trial funded by the DoD Midbrain organoids from…Read more

day: Day Two